Login to Your Account

CRO Ergomed gains coagulant pipeline in Haemostatix buy

By Nuala Moran
Staff Writer

Friday, May 6, 2016

LONDON – Ergomed plc is branching out from its core business as a contract research organization (CRO) to acquire Haemostatix Ltd., a specialist in synthetic coagulants for use in surgery.

To continue reading subscribe now to Latest News

Learn More about Latest News

Already a subscriber? Sign In or Buy now to activate your subscription